Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of insulin syringes market.

PORTLAND, OREGON, UNITED STATES, October 12, 2022 /EINPresswire.com/ --
Allied Market Research recently published a report, titled, "𝐈𝐧𝐬𝐮𝐥𝐢𝐧 𝐒𝐲𝐫𝐢𝐧𝐠𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐒𝐲𝐫𝐢𝐧𝐠𝐞 𝐒𝐢𝐳𝐞 (3/10 𝐜𝐜 𝐒𝐲𝐫𝐢𝐧𝐠𝐞 (0.3𝐦𝐥), 1/ 2 𝐜𝐜 𝐒𝐲𝐫𝐢𝐧𝐠𝐞 (0.5𝐦𝐥), 1𝐜𝐜 𝐬𝐲𝐫𝐢𝐧𝐠𝐞 (1𝐦𝐥), 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 (𝐓𝐲𝐩𝐞-1 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐚𝐧𝐝 𝐓𝐲𝐩𝐞-2 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬), 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 & 𝐂𝐥𝐢𝐧𝐢𝐜𝐬, 𝐇𝐨𝐦𝐞𝐜𝐚𝐫𝐞 𝐒𝐞𝐭𝐭𝐢𝐧𝐠𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 2021–2030". As per the report, the global insulin syringes industry was pegged at $1.56 billion in 2020, and is expected to reach $2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.

𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/3740

An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes. The needle is usually thin and short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. it serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Further, the size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.

𝐌𝐚𝐣𝐨𝐫 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡

Insulin syringes market are increase in the incidence of obesity and adoption of unhealthy lifestyle across the world supplement the market growth. In addition, rise in healthcare spending for diabetes across the world also fuel the growth of insulin syringes market. Furthermore, surge in the prevalence of various chronic diseases such as type1 and type2 diabetes, is another major factor that boosts the market growth. However, increase use of insulin pens and high costs of advanced insulin syringes are the factors that could hinder the growth of market. Conversely, growing in awareness of insulin syringes among population in developing economies is expected to offer lucrative opportunities during the forecast period.

𝐂𝐨𝐯𝐢𝐝-19 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

➤ The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution.

➤ Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/3740

𝐓𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐢𝐨𝐧'𝐬 𝐬𝐡𝐚𝐫𝐞

By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

➤Novo Nordisk A/S
➤Abbott Laboratories
➤Biocon Ltd.
➤Cardinal Health Inc.
➤Terumo Corporation
➤Eli Lilly and Company
➤Beckton and Dickinson Company
➤Nipro Medical Corporation
➤Medline Industries
➤Hindustan syringe and medical device Ltd.

𝐁𝐲 𝐒𝐲𝐫𝐢𝐧𝐠𝐞 𝐒𝐢𝐳𝐞

3/10 CC Syringe (0.3ml)
1/2 CC Syringe (0.5ml)
1CC Syringe (1ml)
Others

𝐁𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞

Type 1 Diabetes
Type 2 Diabetes)

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫
Hospitals & Clinics
Homecare Settings
Others)

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚

U.S.
Canada
Mexico
𝐄𝐮𝐫𝐨𝐩𝐞
Germany
France
UK
Italy
Spain
Rest of Europe

𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜

Japan
China
India
Australia
South Korea
Rest of Asia-Pacific

𝐋𝐀𝐌𝐄𝐀

Brazil
South Africa
Saudi Arabia
Rest of LAMEA

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/3740

𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?

Q1. What is the market value of Insulin Syringes Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Insulin Syringes Market in 2020?
Q4. Which is base year calculated in the Insulin Syringes Market report?
Q5. Does the Insulin Syringes Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Insulin Syringes Market?
Q7. Does the Insulin Syringes Market report provides Value Chain Analysis?
Q8. What are the key trends in the Insulin Syringes Market report?

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

𝐀𝐧𝐭𝐢𝐧𝐮𝐜𝐥𝐞𝐚𝐫 𝐀𝐧𝐭𝐢𝐛𝐨𝐝𝐲 𝐓𝐞𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 2031 https://www.alliedmarketresearch.com/antinuclear-antibody-test-market

𝐒𝐢𝐧𝐠𝐥𝐞 𝐂𝐞𝐥𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 2031 https://www.alliedmarketresearch.com/single-cell-analysis-market-A06188

𝐈𝐦𝐦𝐮𝐧𝐨𝐡𝐢𝐬𝐭𝐨𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 2031 https://www.alliedmarketresearch.com/immunohistochemistry-market-A11199

𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 2031 https://www.alliedmarketresearch.com/compounding-pharmacies-market-A11920

𝐓𝐞𝐧𝐝𝐨𝐧 𝐑𝐞𝐩𝐚𝐢𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 2031 https://www.alliedmarketresearch.com/tendon-repair-market-A17088

𝐎𝐫𝐭𝐡𝐨𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 - 2025 https://www.alliedmarketresearch.com/orthobiologics-market

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn